Pharmacy Times January 10, 2023
Approximately half of patients with heart failure do not require an implantable monitoring device or do not qualify for thoracic monitoring.
A novel wearable device may improve the treatment of heart failure by performing real time continuous monitoring of the physiological parameters associated with heart failure, according to researchers from Florida Atlantic University (FAU) College of Engineering and Computer Science in collaboration with FAU’s Christine E. Lynn College of Nursing. Their research on the prototype device was published in Scientific Reports.
“Approximately 1 in 4 patients with heart failure are readmitted within 30 days of discharge from the hospital and about half are readmitted within 6 months,” said Mary Ann Leavitt, PhD, co-author and an assistant professor in the Christine...
Today's Sponsors
Today's Sponsor